ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 154 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $329,000 | -34.2% | 15,075 | -9.9% | 0.01% | -36.4% |
Q3 2021 | $500,000 | -54.8% | 16,731 | -32.9% | 0.01% | -54.2% |
Q2 2021 | $1,105,000 | +3.6% | 24,948 | +3.7% | 0.02% | +4.3% |
Q1 2021 | $1,067,000 | +69.1% | 24,054 | +109.2% | 0.02% | +91.7% |
Q4 2020 | $631,000 | +37.2% | 11,500 | -42.9% | 0.01% | 0.0% |
Q3 2020 | $460,000 | -8.5% | 20,127 | -16.2% | 0.01% | -14.3% |
Q2 2020 | $503,000 | +49.3% | 24,024 | -0.6% | 0.01% | +7.7% |
Q1 2020 | $337,000 | -25.9% | 24,171 | +20.9% | 0.01% | +85.7% |
Q4 2019 | $455,000 | +95.3% | 20,000 | 0.0% | 0.01% | +40.0% |
Q3 2019 | $233,000 | -8.6% | 20,000 | +17.6% | 0.01% | -28.6% |
Q2 2019 | $255,000 | +16.4% | 17,000 | +36.0% | 0.01% | +40.0% |
Q1 2019 | $219,000 | +5.8% | 12,500 | -10.7% | 0.01% | -44.4% |
Q4 2018 | $207,000 | – | 14,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |